In comparison, rasagiline, the therapeutically used MAO-B inhibitor in PD, exerted IC50 values of 412 nM for MAO-A and of 4.43 nM for MAO-B (Youdim et al. 2001). This evidence concerns the gene MAOA and Parkinson disease.